#116401
Re: Farmas USA
REGN
Hay más sobre Dupixent:
THE LANCET PUBLISHES RESULTS FROM TWO POSITIVE PHASE 3 TRIALS OF DUPIXENT® (DUPILUMAB) IN SEVERE CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)
https://newsroom.regeneron.com/news-releases/news-release-details/lancet-publishes-results-two-positive-phase-3-trials-dupixentr
Hay más sobre Dupixent:
THE LANCET PUBLISHES RESULTS FROM TWO POSITIVE PHASE 3 TRIALS OF DUPIXENT® (DUPILUMAB) IN SEVERE CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)
https://newsroom.regeneron.com/news-releases/news-release-details/lancet-publishes-results-two-positive-phase-3-trials-dupixentr